Dupixent 300 MG/2 ML pen 2ML
Ended Awarded
- Contract number
- SPE2DR26F5M58
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $11,010
Award facts
- Contract value 100% obligated
- $11,010.03 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a firm fixed price delivery order valued at $11,010.03 to AmerisourceBergen Drug Corp for the supply of DUPIXENT 300 mg/2 ml pen injectors (2 ml). The contract was competitively awarded without a set-aside designation and is scheduled for completion by November 17, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the delivery from its corporate office location in the same city. This delivery order is issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends through December 2026.
DUPIXENT (dupilumab) is a biologic medication indicated for multiple conditions including moderate-to-severe atopic dermatitis, asthma, and chronic rhinosinusitis with nasal polyps. The procurement supports the Defense Health Agency and broader military healthcare operations through AmerisourceBergen's comprehensive global pharmaceutical support vehicle. The IDC enables flexible fulfillment of pharmaceutical and medical supply requirements across multiple therapeutic domains to support military healthcare programs worldwide. This delivery order exemplifies the routine pharmaceutical procurement activities under the larger SPE2DX contract, which positions AmerisourceBergen as a critical vendor for federal medical supply needs serving defense and veteran healthcare systems.
Quick answers
Who was awarded contract SPE2DR26F5M58?
SPE2DR26F5M58 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 14, 2025.
How much is contract SPE2DR26F5M58 worth?
The government has obligated $11,010 on SPE2DR26F5M58.
Is contract SPE2DR26F5M58 an order under another contract?
Yes. SPE2DR26F5M58 is a delivery order under SPE2DR25D3101, an indefinite delivery contract.
Was contract SPE2DR26F5M58 competed?
The extent of competition for SPE2DR26F5M58 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award